Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™ [Yahoo! Finance]
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
Microbot Medical Inc. (NASDAQ: MBOT) had its price target lowered by analysts at HC Wainwright from $8.00 to $7.00. They now have a "buy" rating on the stock.
Microbot Medical Shares Status Following Recent Geopolitical Events [Yahoo! Finance]
Microbot Medical Shares Status Following Recent Geopolitical Events